G

Guardian Pharmacy Services Inc
NYSE:GRDN

Watchlist Manager
Guardian Pharmacy Services Inc
NYSE:GRDN
Watchlist
Price: 20.55 USD -0.72% Market Closed
Market Cap: 1.3B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one GRDN stock under the Base Case scenario is 28.15 USD. Compared to the current market price of 20.55 USD, Guardian Pharmacy Services Inc is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRDN Relative Value
Base Case
28.15 USD
Undervaluation 27%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
83
vs Industry
50
Median 3Y
1
Median 5Y
1
Industry
2
Forward
0.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-13
Median 5Y
-13
Industry
17.4
Forward
28
More Details
17.2
P/OCF
P/OCF
Price to OCF
17.2
vs History
75
vs Industry
10
Median 3Y
17.9
Median 5Y
17.9
Industry
10.5
More Details
108.7
P/FCFE
P/FCFE
Price to FCFE
108.7
vs History
58
vs Industry
12
Median 3Y
111.6
Median 5Y
111.6
Industry
13.4
More Details
8.3
P/B
P/B
Price to Book Value
8.3
vs History
83
vs Industry
7
Median 3Y
8.8
Median 5Y
8.8
Industry
1.6
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
83
vs Industry
52
Median 3Y
1
Median 5Y
1
Industry
3
Forward
0.9
More Details
5
EV/GP
EV/GP
Enterprise Value to Gross Profit
5
vs History
83
vs Industry
35
Median 3Y
5.2
Median 5Y
5.2
Industry
6.5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-31.5
Median 5Y
-31.5
Industry
10.7
Forward
12.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
-21.6
Industry
12.9
Forward
20.1
More Details
17
EV/OCF
EV/OCF
Enterprise Value to OCF
17
vs History
75
vs Industry
11
Median 3Y
17.8
Median 5Y
17.8
Industry
11.3
More Details
24.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.1
vs History
75
vs Industry
7
Median 3Y
25.2
Median 5Y
25.2
Industry
12.1
More Details
5.9
EV/IC
EV/IC
Enterprise Value to IC
5.9
vs History
58
vs Industry
13
Median 3Y
6
Median 5Y
6
Industry
1.6
More Details

Multiples Across Competitors

GRDN Competitors Multiples
Guardian Pharmacy Services Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Guardian Pharmacy Services Inc
NYSE:GRDN
1.3B USD 1 -12.7 -41.1 -22.8
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
US
GE Vernova LLC
NYSE:GEV
175.9B USD 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
100.8B USD 293 3 350.6 2 847.8 2 947.7
NL
Nepi Rockcastle NV
JSE:NRP
83.6B Zac 0 0 0 0
US
CoreWeave Inc
NASDAQ:CRWV
56.4B USD 0 0 0 0
US
Coupang Inc
F:788
45.9B EUR 1.7 211 49 89.9
US
Circle Internet Group Inc
NYSE:CRCL
42.9B USD 0 0 0 0
CH
Galderma Group AG
SIX:GALD
31.9B CHF 0 0 0 0
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
598.3T IDR 17.8 99.5 48.4 48.4
US
Symbotic Inc
NASDAQ:SYM
31.2B USD 15.4 -2 523.1 -456.4 -292.9
P/S Multiple
Revenue Growth P/S to Growth
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average P/S: 65.8
1
8%
0.1
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
9%
N/A
US
C
China Industrial Group Inc
OTC:CIND
293
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-4%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
1.7
14%
0.1
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available
31%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
14%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
17.8
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
15.4
25%
0.6
P/E Multiple
Earnings Growth PEG
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average P/E: 1 220.4
Negative Multiple: -12.7 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
42%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 350.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
211
129%
1.6
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available
52%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
75%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
99.5
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 523.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average EV/EBITDA: 981.7
Negative Multiple: -41.1 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
44%
N/A
US
C
China Industrial Group Inc
OTC:CIND
2 847.8
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
7%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available
143%
N/A
US
Coupang Inc
F:788
49
55%
0.9
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
23%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
48.4
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -456.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average EV/EBIT: 1 028.7
Negative Multiple: -22.8 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
80%
N/A
US
C
China Industrial Group Inc
OTC:CIND
2 947.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
11%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
89.9
77%
1.2
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
34%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
48.4
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -292.9 N/A N/A

See Also

Summary
GRDN intrinsic value, competitors valuation, and company profile.
DCF Valuation
GRDN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GRDN stock valuation using valuation multiples.
Wall Street Estimates
GRDN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GRDN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 270,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.